Skin cancer treatment with targeted therapy

Targeted therapy for skin cancer affects some factors (most often various molecules, proteins, genes, etc. ) necessary for the tumor's further growth and development. As a result, different crucial chains in the skin cancer cells' metabolic cycle break down, and the tumor slowly begins to regress. Often, targeted therapy might be combined with other skin cancer treatment methods, including chemotherapy, surgery, and immune therapy. Therefore, before starting this treatment, medical practitioners must evaluate the patient's condition and prescribe various lab tests and other examinations. Nowadays, many available approaches to performing a successful targeted therapy are available. Still, before starting any treatment actions, it might be necessary to perform genetic mutation testing, immunohistochemistry test, and other tests to determine the most suitable mediations for targeted therapy. For now, BRAF inhibitors, MEK inhibitors, C-KIT inhibitors, and many other options are available for patients with skin cancer. In most cases, drugs for targeted medications deliver via intravenous injections. A single dosage intake might take up to a few hours, and patients often get prolonged rest periods before the next treatment session. Sometimes, patients with advanced skin cancer might need up to 7-8 courses of targeted therapy to achieve desired results.